Skip to main content
. 2012 Apr 18;2012:175408. doi: 10.1155/2012/175408

Figure 3.

Figure 3

Combination therapy using cisplatin and the antagonist of PAFR is more efficient than either therapy alone (a) Average tumour volume in each experimental group (±SEM) measured daily. (b) Percentage of complete tumour regression in each experimental condition.